BMO Capital Keeps Their Buy Rating on Ingevity (NGVT)
In a report released today, John McNulty from BMO Capital maintained a Buy rating on Ingevity, with a price target of $68.00. The company’s shares opened today at $57.93.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
McNulty covers the Basic Materials sector, focusing on stocks such as Dow Inc, LyondellBasell, and PPG Industries. According to TipRanks, McNulty has an average return of 2.4% and a 54.12% success rate on recommended stocks.
Currently, the analyst consensus on Ingevity is a Moderate Buy with an average price target of $60.33.
NGVT market cap is currently $2.14B and has a P/E ratio of -9.72.
Read More on NGVT:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.